BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company in Mass. history

RUBIUS THERAPEUTICS raised $241 million in its IPO Wednesday.
PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts history by more than $90 million, according to the Boston Business Journal Wednesday. The company had previously projected a $200 million IPO. The previous highest IPO for a biotech company in…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display